No takes yet. Share an insight, caveat, or question.
The mechanism of flecainide's antiarrhythmic effect in CPVT remains controversial, highlighting the need for detailed analysis of its interaction with the cardiac ryanodine receptor (RyR2).
Smith et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: